The efficacy of ocrelizumab for multiple sclerosis

0
This summary will present the most up to date findings from a recent Cochrane review.1 Background It is estimated that a total of 2.8 million people...

How pharmacists are reducing chemical restraint

0
For years it seemed impossible to achieve, but markedly reducing chemical restraint is on its way.

Meet PSA’s new President

0
The new President of the Pharmaceutical Society of Australia (PSA) is Dr Chris Freeman – currently Clinical Senior Lecturer and the Director of the...

Aged care ECP

0
A chance to work on site in aged care helped ECP of the Year Dee-Anne Hull MPS uncover a new level of passion for the profession.

Is combined NRT therapy the best bet for smoking cessation?

Groundbreaking new research has found that current smokers are three times more likely to die from cardiovascular disease (CVD), but these risks greatly decrease...

New PSA Fellows announced

0
In 2026, PSA recognised a distinguished cohort of pharmacists as PSA Fellows and Life Fellows at the Fellows Dinner, held on Day one of PSA26.